Medicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11 Monotherapy Aug 1, 2024 07:00AM
Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights Jun 27, 2024 08:18AM